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Summary Actinomycosis is a rare, chronic disease caused by a group of anaerobic Gram-positive
bacteria that normally colonize the mouth, colon, and urogenital tract. Infection involving the
cervicofacial area is themost common clinical presentation, followed by pelvic region and thoracic
involvement. Due to its propensity to mimicmany other diseases and its wide variety of symptoms,
clinicians should be aware of its multiple presentations and its ability to be a ‘great pretender’. We
describe herein three cases of unusual presentation: an inferior caval vein syndrome, an acute
cholecystitis, and an acute cardiac tamponade. We review the literature on its epidemiology,
clinical presentation, diagnosis, treatment, and prognosis.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
Actinomycosis is a rare, chronic disease caused by a group of
anaerobic Gram-positive bacteria that normally colonize the
mouth, colon, and urogenital tract. Humans are the natural
reservoir and there is no documented person-to-person trans-
mission of the disease.1
Since these microorganisms are not virulent, mucosal
disruption is needed to lead to infection, which in turn is
characterized by a tendency to mimic malignancy due to its
capacity to invade surrounding tissues and to form masses;2,3
therefore clinical presentations are multiple.* Corresponding author. Tel.: +56 2 4929143.
E-mail address: fnacevedo@gmail.com (F. Acevedo).
1201-9712/$32.00 # 2007 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2007.10.006We describe herein three patients with uncommon clinical
presentations of actinomycosis compromising different
organs and a short review of the literature on the topic.
Case 1
The first case is that of a 37-year-old man with a past medical
history of pectoral actinomycosis diagnosed by biopsy in
2002, and chronic lower back pain of unknown etiology. He
was admitted because of a 2-month history of progressive
non-pitting swelling of both inferior extremities associated
with genital and abdominal wall edema. He also was also
suffering from weight loss, and there were multiple small
painful nodules with purulent discharge on his lower back
(Figure 1).
On examination hewas afebrile and all lumbarmovements
were severely restricted by pain. There were multiple, andPublished by Elsevier Ltd. All rights reserved.
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Figure 1 Multiple small nodules on the lower back of a patient
with abdominal actinomycosis. Purulent discharge was noted.not well circumscribed, tender nodules over the lumbosacral
region. Pressure on these skin lesions produced pain that the
patient described as radiating into the adjacent bones, and
purulent discharge was noted. There was bilateral non-pit-
ting leg edema associated with genital enlargement and
abdominal collateral circulation. A neurological examination
was normal. There were no palpable lymph nodes. The
remainder of the examination was normal.
His hemoglobin level was 7 mg/dl and his serum iron
concentration, transferrin level, and percent saturation of
transferrin were consistent with anemia of chronic disease.
His urea nitrogen level was 26 mg/dl and serum creatinine
level was 1.2 mg/dl. Renal ultrasonography showed mild
bilateral hydronephrosis, which was complemented by a
computed tomography (CT) scan showing multiple paraver-
tebral and retroperitoneal masses compressing structures
such as both ureters and inferior cava vein. The CT scan also
demonstrated images consistent with cava vein thrombosis.
Vertebral involvement was seen mainly at the level of L5 with
images of several osteolytic lesions (Figure 2).
A skin biopsy from the affected area on the back was
consistent with actinomycosis involvement. He was antic-
oagulated for a period of 6 months. Concomitantly, he was
treated with intravenous penicillin for 4 weeks and on an
outpatient basis with oral amoxicillin for 12 months with anFigure 2 Abdominal computed tomography showing multiple
paravertebral and retroperitoneal masses, a number of which
are compressing some structures.excellent response. Eight months later the patient had recov-
ered his weight, had no back pain, and was fully ambulatory.
A new CT scan showed a significant reduction in the abdom-
inal masses.
Case 2
The second case is that of a 41-year-old woman who pre-
sented to the emergency department with a 3-month history
of intermittent severe epigastric pain, which became steady,
radiating to the right upper quadrant.
Abdominal ultrasonography showed stones in the gallblad-
der and a laparoscopic cholecystectomy was performed.
During the procedure the surgeon had to convert to an open
operation due to intra-operative findings suggesting gallblad-
der cancer. The stomach and right colon were tightly
attached to a scleroatrophic gallbladder and separation of
these organs was extremely difficult.
Microscopic analyses of the gallbladder showed an acute
inflammatory process with a suppurating focus and bacterial
colonies consistent with actinomycosis.
She had no complications during the postoperative period
and intravenous ceftriaxone for 4 weeks was indicated before
changing to amoxicillin. She was discharged fully recovered
to complete treatment on an outpatient basis.
Case 3
The third case is that of a 51-year-old man with an unremark-
able past medical history who was admitted because of a 1-
week history of productive cough, with small amounts of
whitish sputum. The day before admission, he had an acute
onset severe precordial pain, with no irradiation, and this
was alleviated by leaning forward.
On admission, his vital signs were normal, the jugular
venous pressure was not elevated, but heart sounds were
diminished. No friction rub was found and cardiac enzymes
were normal. An electrocardiogram showed diffuse STeleva-
tion, and a chest X-ray showed an enlarged cardiac silhouette
with clear lung fields (Figure 3). The echocardiogram showed
mild pericardial effusion. Aspirin 500 mg was initiated, but
four days later his temperature had increased to 38 8C. Tests
for HIV and hepatitis B and C were all negative and rheuma-
tologic blood tests were normal. An acid-fast stain on sputum
was negative.Figure 3 Electrocardiogram showing diffuse ST elevation con-
sistent with the diagnosis of pericarditis.
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Figure 4 Thoracic computed tomography showing evidence of
pericardial effusion in a patient with pericardial actinomycosis.His condition worsened presenting severe dyspnea and an
elevated jugular pressure, and pulsus paradoxus was noted. A
new echocardiogram and a thoracic CT scan showed acute
cardiac tamponade and pleural effusion (Figure 4).
On emergency thoracotomy, purulent pericardial fluid
was drained and the pericardium appeared irregular and
thickened with multiple nodules mimicking neoplastic
lesions. Chemical analyses of the pericardial fluid revealed
a leukocyte count of 30  109/l (94% neutrophils), glucose
and total protein content of 1 mg/dl and 5.2 g/dl, respec-
tively, and adenosine deaminase (ADA) of 67.4 U/l. No
acid-fast bacilli were found in the pericardial fluid and
results of culture were negative. Lung and pericardial
histologic examination were consistent with lung and peri-
cardial actinomycosis.
Intravenous penicillin was started, but dyspnea, elevated
jugular pressure, and edema remained. Transesophageal
echocardiography was consistent with constrictive pericar-
ditis, but no surgery was needed. He was treated with
intravenous penicillin for 4 weeks and amoxicillin thereafter.
Following 4 months of treatment the patient was finally
discharged in a stable condition and with minimal symptoms
to complete 6 months of antibiotic treatment.
Discussion
Actinomycosis is an infection caused by anaerobic Gram-
positive Actinomyces species, which belong to the natural
flora of the oral cavity, gastrointestinal tract, and urogenital
tract.4,5 At least 30 species have been isolated, of which the
most commonmicroorganisms causing infections are A. israe-
lii, A. naeslundii, A. odontolyticus, A. viscosus, A. meyeri,
and A. gerencseriae.6
Actinomyces are closely related to Nocardia species, and
both were once considered fungi because of their branching
filaments,1 but are currently classified as bacteria. Histo-
pathologic examination of bones from individuals diagnosed
with actinomycosis were recently evaluated by Rothschild
et al.7 Results from his work showed that actinomycosis has
unique features that distinguish it from other microorganisms
but, surprisingly, it has some amazing similarities to fungal
infections, bringing into question its current classification as
a bacterium.Actinomycosis is endemic, occurring worldwide. It has no
predilection for age, race, season, or occupation,8 and
although not considered an opportunistic infection, it has
been described in patients with HIV9,10 and leukemia,11 and
in patients with other causes of immunodeficiency. However
no underlying disease or immunosuppression is found in most
patients.12
These infections usually involve the cervicofacial, thor-
acic and abdominopelvic regions, and the CNS,1 and no
person-to-person transmission has yet been documented.
During the 1970s, an annual incidence of 1 case per
300 000 was found in the Cleveland area, however improved
dental hygiene and the widespread use of antibiotic treat-
ment have contributed to a decrease in this incidence.
Abdominal actinomycosis accounts for 20% of all actino-
mycosis13 and is the most indolent and non-specific presenta-
tion, therefore diagnosis is quite difficult for clinicians.
Clinical and laboratory findings are non-specific and a lot
of conditions have been described as a possible initiating
event, such as diverticulitis, appendicitis,14 peptic ulcer
disease, foreign body,15 bowel surgery, and the utilization
of an intra-uterine contraceptive device. Virtually all organs
have been reported to be compromised.
Nevertheless, inferior cava syndrome is an uncommon
manifestation or complication of actinomycosis. After a wide
literature search in PubMed/Medline only one case was found
of a patient with disseminated disease.16 In our patient, the
diagnosis was made by clinical examination, CTscan showing
vascular involvement with thrombosis, and a good response
to anticoagulation therapy. Actinomycosis complicated with
ureteral compression is also an unusual presentation.17
Gallbladder actinomycosis is a rare presentation that
can masquerade as a chronic cholecystitis but more fre-
quently presents as an acute disease.18 Because of the
tendency to form masses and to invade other organs, cancer
and actinomycosis are almost always confused, the latter
being diagnosed only after a microscopic histopathologic
examination.19 However, there is one reported case of biliary
actinomycosis associated with an adenocarcinoma of the
gallbladder.20 Gallbladder actinomycosis may spread to the
liver,21,22 but cholecystic or common bile duct involvement is
very rare, being described only twice.23,24
There are no specific radiological features on ultrasound
or CTscan to aid the diagnosis. Sometimes a CTcan be helpful
in the presence of a contrast-enhancing multicystic lesion in
order to approach biopsy.8 When the abdominopelvic acti-
nomycosis involves the gastrointestinal tract, a bowel wall
thickening and a peritoneal mass that tends to invade across
tissue planes can be seen.25
Actinomycosis infection of the bone is mainly due to
adjacent tissue infection, but it can also be seen in some
fractures or hematogenous spread.6 Involvement of the ver-
tebral column has frequently been reported, and because of
slow disease progression the lesions tend to be spheroid and
surrounded by periosteal bone formation.7 Vertebral collapse
is not a common feature and osteolytic damage, as in our
patient, is rare.26 Cutaneous sinus tracts usually develop.
Thoracic actinomycosis may involve lungs, pleura, med-
iastinum, chest wall, or pericardium.1 Pulmonary actinomy-
cosis accounts for 15—45% of all cases reported and cardiac
involvement only 2%. Of cases where the heart is involved,
80% have infection of the pericardium.27 Mediastinal infec-
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Other forms of infection include transdiaphragmatic or
rarely, hematogenous dissemination.
Chest pain, dyspnea, fever, weight loss, and cough are
very common manifestations of thoracic and pericardial
involvement.6,28 Examination of pericardial fluid may reveal
a polymorphonuclear leukocyte predominance, but detec-
tion of sulfur granules and culture of the Actinomyces organ-
ism are very difficult29 with only 26% of cultures being
positive.28 Different cut-off values for ADA activity, ranging
from 30 to 60 U/l, have been suggested as being indicative of
tuberculous pericarditis,30 however high levels have also
been found in another infectious conditions with purulent
fluid.31 In endemic areas, an ADA cut-off value of 60 U/l has a
100% sensitivity and an 80% specificity for tuberculous peri-
carditis.32 We found no data in the medical literature regard-
ing ADA levels and actinomycosis. However our patient’s
pericardium biopsy did not demonstrate the presence of
granulomas making the diagnosis of tuberculous pericarditis
very unlikely.
Actinomyces species are susceptible tomany antibiotics in
vitro.33 Clinical experience supports the use of penicillin G as
the drug of choice, and in order to avoid relapse, prolonged
treatment is advisable.1 Therapy should be individualized,
but high doses (18—24 million units/day) of penicillin over a
long period of time (2—6 weeks) followed by oral therapy
with penicillin or amoxicillin to complete 6 to 12 months
seems reasonable.6 However, there are some reports of
successful short-term treatment with beta-lactam antibio-
tics in special circumstances.34
For penicillin-allergic patients, doxycycline, minocycline,
tetracycline, clindamycin, erythromycin, and cephalosporins
have been proven to be effective in case reports.29,35—38 A
recent in vitro study assessing the susceptibility of human
clinical isolates of Actinomyces species to different antimi-
crobial agents showed that bacterial identification may be
critical because of the resistance to some antibiotics.33
Surgical treatment is controversial and may include incision
and drainage of abscesses, resection of necrotic tissue, and
curettage of bone.1
The prognosis for treated infections is excellent if it is
recognized early. Hematogenous dissemination is a relatively
frequent complication of actinomycosis, especially as a
result of thoracic disease. It produces manifestations that
can be easily mistaken for metastasic disease, with multiple
nodules in virtually any organ or tissue. However, despite the
extent of the disease, it has a good prognosis when discov-
ered in time.6,39
Mortality ranges from 0 to 28% depending mainly on the
site of infection and the time to diagnosis.1,40—42 Actinomy-
cosis of the central nervous system has the greatest mortality
with neurologic sequelae being reported in half of these
patients.42
Conclusions
Actinomycosis is still a disease that poses a great diagnostic
challenge because of its insidious course and non-specific
symptoms. Because of this wide variety of clinical presenta-
tions reported in the literature and its tendency to mimic
different diseases, actinomycosis acts as a ‘great preten-
der’.We emphasize the importance of early diagnosis with a
simple Gram stain, and that delayed treatment can lead to
increased morbidity and even mortality.
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